TY - JOUR

T1 - Incidence of premature battery depletion in subcutaneous cardioverter-defibrillator patients

T2 - insights from a multicenter registry

AU - Lüker, Jakob

AU - Strik, Marc

AU - Andrade, Jason G.

AU - Raymond-Paquin, Alexandre

AU - Elrefai, Mohamed Hassan

AU - Roberts, Paul R.

AU - Pérez, Óscar Cano

AU - Kron, Jordana

AU - Koneru, Jayanthi

AU - Franqui-Rivera, Hilton

AU - Sultan, Arian

AU - Ernst, Angela

AU - Schmitt, Jörn

AU - Pott, Alexander

AU - Veltmann, Christian

AU - Srinivasan, Neil T.

AU - Collinson, Jason

AU - van Stipdonk, Antonius M.W.

AU - Linz, Dominik

AU - Fluschnik, Nina

AU - Tönnis, Tobias

AU - Haeberlin, Andreas

AU - Ploux, Sylvain

AU - Steven, Daniel

N1 - Publisher Copyright: © 2023, The Author(s).

PY - 2024

Y1 - 2024

N2 - Background: The subcutaneous ICD established its role in the prevention of sudden cardiac death in recent years. The occurrence of premature battery depletion in a large subset of potentially affected devices has been a cause of concern. The incidence of premature battery depletion has not been studied systematically beyond manufacturer-reported data. Methods: Retrospective data and the most recent follow-up data on S-ICD devices from fourteen centers in Europe, the US, and Canada was studied. The incidence of generator removal or failure was reported to investigate the incidence of premature S-ICD battery depletion, defined as battery failure within 60 months or less. Results: Data from 1054 devices was analyzed. Premature battery depletion occurred in 3.5% of potentially affected devices over an observation period of 49 months. Conclusions: The incidence of premature battery depletion of S-ICD potentially affected by a battery advisory was around 3.5% after 4 years in this study. Premature depletion occurred exclusively in devices under advisory. This is in line with the most recently published reports from the manufacturer. Trial registration: ClinicalTrials.gov Identifier: NCT04767516.

AB - Background: The subcutaneous ICD established its role in the prevention of sudden cardiac death in recent years. The occurrence of premature battery depletion in a large subset of potentially affected devices has been a cause of concern. The incidence of premature battery depletion has not been studied systematically beyond manufacturer-reported data. Methods: Retrospective data and the most recent follow-up data on S-ICD devices from fourteen centers in Europe, the US, and Canada was studied. The incidence of generator removal or failure was reported to investigate the incidence of premature S-ICD battery depletion, defined as battery failure within 60 months or less. Results: Data from 1054 devices was analyzed. Premature battery depletion occurred in 3.5% of potentially affected devices over an observation period of 49 months. Conclusions: The incidence of premature battery depletion of S-ICD potentially affected by a battery advisory was around 3.5% after 4 years in this study. Premature depletion occurred exclusively in devices under advisory. This is in line with the most recently published reports from the manufacturer. Trial registration: ClinicalTrials.gov Identifier: NCT04767516.

KW - Advisory

KW - Implantable cardioverter-defibrillator

KW - Longevity

KW - Premature battery depletion

KW - Subcutaneous ICD

UR - http://www.scopus.com/inward/record.url?scp=85146384107&partnerID=8YFLogxK

U2 - 10.1007/s10840-023-01468-1

DO - 10.1007/s10840-023-01468-1

M3 - Journal article

C2 - 36652082

AN - SCOPUS:85146384107

JO - Journal of Interventional Cardiac Electrophysiology

JF - Journal of Interventional Cardiac Electrophysiology

SN - 1383-875X

ER -